| 摘要: |
| 目的 评价健康受试者空腹和餐后条件下单剂量服用盐酸西替利嗪片受试制剂和参比制剂是否具有生物等效性。方法 采用随机、开放、单剂量、自身交叉设计,液质联用(LC-MS/MS)法测定健康受试者空腹或餐后给药后血浆中西替利嗪的药物浓度,使用Phoenix Winnonlin 8.0软件计算药动学参数,使用SAS 9.4软件进行生物等效性评价。结果 空腹BE试验:24名健康受试者分别单次空腹服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为100.18%、96.37%、96.00%,其90%置信区间分别为95.72% ~ 14.84%、92.37% ~ 100.55%、91.77% ~ 100.42%,均落在等效区间80.00% ~ 125.00%之间;餐后BE试验:22名健康受试者分别单次餐后服用受试制剂和参比制剂10 mg后,Cmax、AUC0-t、AUC0-∞几何均数的比值分别为103.98%、102.19%、101.58%,其90%置信区间分别为98.31% ~ 109.97%、98.33% ~ 106.20%、98.07% ~ 105.20%,均落在等效区间80.00% ~ 125.00%之间。结论 两种制剂对于空腹和餐后条件下的健康成年受试者具有生物等效性。 |
| 关键词: 西替利嗪 生物等效性试验 药代动力学 |
| DOI:10.13506/j.cnki.jpr.2020.09.006 |
| 基金项目: |
|
|
|
| Bioequivalence tests of Cetirizine Hydrochloride Teblets in healthy volunteers |
| SI Ge1,GUO Jianyan2,ZHANG Honghen2,GAO Juan3,ZHENG Zhonghui2 |
| (Cetirizine; Bioequivalence; Pharmacokinetic) |
| Abstract: |
| Objective To evaluate the bioequivalence of preparations and reference subjects in a single dose of cetirizine hydrochloride tablets under fasting and postprandial conditions in healthy volunteers.Methods A random, open label, single-dose, self-crossover test was designed. LC-MS/MS was applied to determine the concentration of cetirizine in plasma of healthy subjects after fasting or postprandial administration, while PHOENIX WINNONLIN 8.0 and SAS 9.4 software were used for pharmacokinetics (PK) parameters calculation and bioequivalence analysis, respectively.Results In the fast test, 24 healthy subjects took the test preparation and the reference preparation 10 mg on a single fasting. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 100.18%, 96.37%, 96.00%, respectively. The 90% confidence intervals of Cmax, AUC0-t, AUC0-∞ are 95.72% ~ 14.84%, 92.37% ~ 100.55%, 91.77% ~ 100.42%, respectively. All these data are falling within the equivalent interval of 80.00% ~ 125.00%. In the postprandial test, 22 healthy subjects took the test and reference preparations 10 mg after a single meal. The ratio of the geometric mean of Cmax, AUC0-t, AUC0-∞ are 103.98%, 102.19% 101.58%, respectively, with 90% confidence intervals of 98.31% ~ 109.97%, 98.33% ~ 106.20%, 98.07% ~ 105.20%, respectively, all of which are falling within the equivalent range of 80.00% ~ 125.00%.Conclusion The two formulations are bioequivalent to healthy adult volunteers under fasting and postprandial conditions. |
| Key words: Cetirizine Bioequivalence Pharmacokinetic |